Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results

Go back to Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results

Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh

August 18, 2022 8:37 AM EDT

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

... More